Outcome Capital LLC has expanded its biotech practice with the addition of Ellen Baron to its executive team.
Baron most recently was a managing director of biopharmaceuticals at Healthios Capital Markets LLC.
Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.
At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.
Outcome Capital adds to biotech practice
Banking Essentials Newsletter: July Edition - Part 3
Banking Essentials Newsletter: July Edition - Part 2
Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration
Taking Loss Given Default Estimation to the Next Level: An Aspiration for All Creditors, Not Just Banks